Screener
Sana Biotechnology SANA Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Sana Biotechnology’s reported figures.
The source filing: Sana Biotechnology’s 10-Q, filed May 11, 2026. Open the filing →
- Filed
- May 11, 2026, 4:10 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-216769
FAQ
- What is Sana Biotechnology's free cash flow?
- Sana Biotechnology (SANA) reported free cash flow of -$37.67M in Q1 2026.
- How has Sana Biotechnology's free cash flow changed year-over-year?
- Sana Biotechnology's free cash flow increased by 22.8% year-over-year, from -$48.79M to -$37.67M.
- What is the long-term trend for Sana Biotechnology's free cash flow?
- Over 4 years (2021 to 2025), Sana Biotechnology's free cash flow has grown at a -15.3% compound annual growth rate (CAGR), from -$280.92M to -$144.77M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.
Ask your AI about Sana Biotechnology's free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude